Summary
- Current Price
- As of today, CGEM price is $13.49, down -3.30% on
- Current Price All-Time High
- CGEM price is currently -77.46% below its historical high of $59.85 set on
- Market Cap
- CGEM current market cap is $797M, up +52.69% over the past 365 days
- PE Ratio
- CGEM PE ratio is unknown
- Revenue
- CGEM current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for CGEM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Cullinan Therapeutics, Inc. |
| Ticker | NASDAQ: CGEM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cullinantherapeutics.com |
| Employees | 111 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $13.49 | |
| Price, 1D Change | -3.30% | |
| $797M | ||
| - | ||
| - | ||
| 0.91 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.72 | ||
| EPS, 1Y Change | -19.62% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.72 | ||
| EPS Estimate | N/A | -$3.10 |
| EPS Est. Change | N/A | +16.85% |
| $0.00 | ||
| Revenue Estimate | N/A | $12.65M |
| Revenue Est. Change | N/A | - |
| Current Price | $13.49 | |
| Price Target | - | $30.00 |
| Price Tgt. Change | - | +122.39% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.94 | -$3.11 | -5.93% | |
| -$3.62 | -$3.72 | -2.90% | |
| -$3.10 | N/A | +16.85% | |
| -$2.92 | N/A | +21.49% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $6.12M | $0.00 | -100.00% | |
| $12.65M | N/A | - | |
| $35.34M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $13.49 | |
| $9.31 | ||
| SMA 200 vs Price | -30.98% | |
| $12.66 | ||
| SMA 50 vs Price | -6.13% | |
| 0.91 | ||
| $1.03 | ||
| 45.80 | ||
| 45.71% | ||
| 75.91% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$3.72 | ||
| -$311.00K | ||
| - | ||
| -$241.65M | ||
| - | ||
| -$219.88M | ||
| - | ||
| -$241.34M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 10.25 | ||
| 10.25 | ||
| - | ||
| - | ||
| 9.16 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.95 | ||
| -1.75 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $408.73M | ||
| $377.90M | ||
| $449.14M | ||
| $386.76M | ||
| $40.41M | ||
| $37.74M | ||
| $2.68M | ||
| $780.00K | ||
| $841.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $219.88M | ||
| $241.34M | ||
| $311.00K | ||
| $0.00 | ||
| $311.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$175.75M | ||
| $179.99M | ||
| $1.09M | ||
| $49.00K | ||
| -$175.80M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | → | |
| Citigroup | ||
| Guggenheim | ||
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Morgan Stanley | → | |
| UBS | → |
Analyst sentiment
Institutional ownership
Screeners with CGEM
FAQ
What is the ticker symbol for Cullinan Therapeutics, Inc.?
The ticker symbol for Cullinan Therapeutics, Inc. is NASDAQ:CGEM
Does Cullinan Therapeutics, Inc. pay dividends?
No, Cullinan Therapeutics, Inc. does not pay dividends
What sector is Cullinan Therapeutics, Inc. in?
Cullinan Therapeutics, Inc. is in the Healthcare sector
What industry is Cullinan Therapeutics, Inc. in?
Cullinan Therapeutics, Inc. is in the Biotechnology industry
What country is Cullinan Therapeutics, Inc. based in?
Cullinan Therapeutics, Inc. is headquartered in United States
When did Cullinan Therapeutics, Inc. go public?
Cullinan Therapeutics, Inc. initial public offering (IPO) was on January 8, 2021
Is Cullinan Therapeutics, Inc. in the S&P 500?
No, Cullinan Therapeutics, Inc. is not included in the S&P 500 index
Is Cullinan Therapeutics, Inc. in the NASDAQ 100?
No, Cullinan Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Cullinan Therapeutics, Inc. in the Dow Jones?
No, Cullinan Therapeutics, Inc. is not included in the Dow Jones index
When was Cullinan Therapeutics, Inc. last earnings report?
Cullinan Therapeutics, Inc.'s most recent earnings report was on November 6, 2025
When does Cullinan Therapeutics, Inc. report earnings?
The next expected earnings date for Cullinan Therapeutics, Inc. is May 7, 2026
Data Sources & References
- CGEM Official Website cullinantherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1789972/000119312526099362/0001193125-26-099362-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1789972/000119312526099362/0001193125-26-099362-index.htm
- CGEM Profile on Yahoo Finance finance.yahoo.com/quote/CGEM
- CGEM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cgem